Brazil recevied 1 million Chinese COVID-19 Vaccines
Brazil recevied 1 million Chinese COVID-19 Vaccines
Brazil recevied 1 million Chinese COVID-19 Vaccines. Brazil received the second lot of 1 million doses of Chinese vaccine.
[Global Times Comprehensive] According to a Reuters report on the 3rd, Brazil’s Butantan Institute received 1 million doses of the COVID-19 vaccine developed in cooperation with Beijing Kexing Zhongwei Biotechnology Company. This is the second batch of vaccines. The first batch of vaccines arrived in Brazil on November 19.
The vaccine is undergoing late-stage testing in the State of Sao Paulo, Brazil. According to reports, the vaccine needs to be used after obtaining approval from the Brazilian National Health Inspection Agency (Anvisa). The Butantan Institute stated that it hopes that the relevant test results will be announced on December 15.
Anvisa said on Wednesday that it is open to approving the emergency use of the COVID-19 vaccine, related vaccines must be later tested in Brazil, and authorization will be analyzed according to the specific circumstances. The agency said it has not received any requests so far.
Related News
Brazil ANVISA Approved the import COVID-19 Vaccine from China
Brazil ANVISA Approved the import COVID-19 Vaccine from China”
Brazil’s health supervision agency approves the import of 6 million doses of China’s COVID-19 (COVID-19) vaccines According to Reuters, on October 23 local time, the Brazilian Health Supervision Agency (ANVISA) issued a statement stating that it had authorized the Butantan Institute, Brazil’s top biomedical research center, to import 6 million doses of COVID-19 from…Short Description
Brazil plans to use Chinese Vaccines
Brazil plans to use Chinese Vaccines
Brazil plans to use Chinese Vaccines Brazil plans to use a Chinese COVID-19 vaccines as part of the national immunization plan. Sao Paulo Governor João Doria said that the federal government has agreed to purchase 46 million doses of vaccine. He said that the immunization program will be launched as early as January 2021. According…
